Poster Abstract Session:
234. Diagnostics - Bacterial Identification & Resistance
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Lysis Centrifugation Method for the Direct Identification of Positive Blood Cultures Using MALDI-TOF MS
Hilal Al Sidairi, M.D; Khalifa BinKhamis, MBBS, FRCPC; Joline Head, MLTC; Ross Davidson, PhD, FCCM, (D)ABMM
Not So Common? Late Neuroborreliosis in a Referred Population
Takaaki Kobayashi, M.D.; Yvonne Higgins, PA, MAS, MS/ITS; Paul Lantos, MD, FIDSA; Michael T. Melia, MD; Paul Auwaerter, MD, MBA, FIDSA
Screening for Lyme Disease with C6 Peptide at a Veterans Hospital in Long Island, NY
Robert Chow, MD; Teresa Khoo, MD; George Psevdos Jr., MD
Posters
  • Final C6 Peptide.pdf (3.2 MB)
  • Lactose vs Non-Lactose Fermenting E. coli: Epidemiology, Clinical Outcomes, and Resistance
    Gokul Yaratha, MD; Sarah Perloff, DO; Kinesh Changala, MBBS
    Colistin Susceptibility Testing Using the MicroScan® Colistin Well
    Joseph Lutgring, MD; Eileen Burd, PhD, D(ABMM)
    Posters
  • Colistin Resistance.pdf (44.9 kB)
  • Performance of TEM-PCR versus Culture for Bacterial Identification in Pediatric Musculoskeletal Infections
    James Wood Jr., MD, MSCI; Cheryl Sesler, MS; Donald Stalons, PhD, D(ABMM), MPH; Elena Grigorenko, PhD; C. Buddy Creech, MD, MPH; Isaac Thomsen, MD, MSCI
    Multifaceted Approach to Optimize Blood Volume Inoculated into Culture Bottles in the Pediatric Intensive Care Unit
    Kensuke Shoji, MD; Norihiko Tsuboi, MD; Ritsuro Arakawa, MD; Kentaro Ide, MD; Akira Kato, Mr.; Isao Miyairi, MD
    Posters
  • ID week 2017_ver.2.pdf (706.4 kB)
  • Quantiferon conversions and reversions among HIV patients on antiretroviral therapy
    Andrea L. Covington, MD; Prakash Shrestha, MD; Ana Fuentes Arzola, MD, MPH; Christopher R. Frei, PharmD, MSc; Jose Cadena Zuluaga, MD
    Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy for Rapid Identification of Non-Fermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis
    Emilie Vallieres, MD, FRCPC; Caroline Quach, MD, MSc, FRCPC, FSHEA; Lisa Lam, BSc; Fabien Rallu, PhD; Michele Langella, BSc; Jacqueline Sedman, PhD; Martin Raymond Sr., MLT; Pierre Lebel, MD, FRCPC; Ashraf Ismail, PhD
    Posters
  • IDWeek_Poster_FTIR_Final.pdf (1.8 MB)
  • Aminoglycoside Susceptibility Agreement between an Automated System and Broth Microdilution for Carbapenem-resistant Enterobacteriaceae
    Brandon Kulengowski, PharmD, MS; Matthew Brignola, BS; Chanah Gallagher, BA; David S. Burgess, PharmD, FCCP, FIDP
    Impact of Automation Process on Microbiological Laboratory Efficiency
    Suhaireirene Suady Barake, MD; Alanna Emrick, MLS (ASCP); Ying Tabak, PhD; Andrew Jasen, MPH; Letha Vankeepuram, MS; David Sellers, RN; Fatma Levent, MD
    Performance Verification of the Accelerate Pheno™ System for Rapid Identification and Antimicrobial Susceptibility Testing from Positive Blood Culture in a Pediatric Population
    Judy Daly, PhD; Aubrie Hopper, MLS, ASCP; Abby Phillips, MLS, ASCP; Mandy Dickey, MLS, ASCP; Ranae Grand-Pre, MLS, ASCP; E. Kent Korgenski, MT, MS; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS; Emily Thorell, MD, MSCI; Anne J. Blaschke, MD, PhD, FIDSA, FPIDS
    Reproducibility of Ceftolozane/Tazobactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
    Amanda Harrington, Ph.D.; Sharon DesJarlais, MT (ASCP); Romney Humphries, PhD; Janet Hindler, MCLS, MT(ASCP); Maria Traczewski, BS; Denise Beasley, MT (ASCP); Regina Brookman, B.S.; Jennifer Chau, Ph.D.; Darcie Carpenter, Ph.D.
    Reproducibility of Ceftazidime/Avibactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
    Romney Humphries, PhD; Janet Hindler, MCLS, MT(ASCP); Amanda Harrington, Ph.D.; Sharon DesJarlais, MT (ASCP); Maria Traczewski, BS; Denise Beasley, MT (ASCP); Regina Brookman, B.S.; Jennifer Chau, Ph.D.; Darcie Carpenter, Ph.D.
    Evaluation of the Accelerate Pheno™ system for the identification and antimicrobial susceptibilty testing of Gram-negative bacteria, compared with conventional laboratory testing.
    Kerry Roulston, FRCPath DipHic MSc BSc; Rebecca Gorton, PGDip MSc BSc; Ekaterini Kazantzaki, MSc; Monica Rebec, MSc; Susan Hopkins, FRCP FRCPI MD MSc BA MBChB; Giovanni Satta, MBBS MSc MBA FRCPath; Damien Mack, FRCPath DTMH MSc MBBS
    Posters
  • IDWeek_2017_poster_FINAL_GS.pdf (707.9 kB)
  • An Evaluation of Vitek2TM Direct Susceptibility Testing (DST) of Gram-Negative Bacteria (GNB) from Positive Blood Cultures (+BC).
    Daniel Gregson, MD; Deirdre Church, MD PhD; Wilson W. Chan, MD; Holly Williscroft, BSc; Lorraine Campbell, MLT; Johann Pitout, MD
    Posters
  • idweek.pdf (391.3 kB)
  • Prospective Evaluation of Accelerate Pheno™ System (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) from Positive Blood Cultures (+BC) using AXDX PhenoTest™ BC Kits
    Barbara M. Willey, ART; Bryan Gascon, BSc; Samantha Lee, BSc; Vita Koren, BSc; Salman Surangiwala, BSc; Aimee Paterson, MSc; Pauline Lo, MLT, ART; Tony Mazzulli, MD FRCPC; Susan M. Poutanen, MD, MPH, FRCPC
    Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections
    Nancy Matic, MD; Barbara Willey, ART; Bryan Gascon, BSc; Samantha Lee, BSc; Vita Koren, BSc; Salman Surangiwala, BSc; Pauline Lo, MLT, ART; Tony Mazzulli, MD FRCPC; Susan M. Poutanen, MD, MPH, FRCPC
    Evaluation of the FilmArray Meningitis/Encephalitis Molecular Panel in a Tertiary Care Public County Hospital
    Tae Hun Kim, MD; Emi Minejima, PharmD; Brad Spellberg, MD; Ira Shulman, MD; Paul Holtom, MD; Tarina Kang, MD; Susan M. Butler-Wu, PhD
    Colistin Susceptibility Testing of Enterobacteriaceae by Agar Dilution (AD), Broth Microdilution (BMD) and Polymyxin NP
    Poornima Ramanan, MD; Nicolynn Cole, MT(ASCP); Peggy Kohner, MT(ASCP); James Uhl, MS; Robin Patel, MD, FIDSA, D(ABMM); Audrey Schuetz, MD
    Significant Reduction of Blood Culture Contamination in the Emergency Department (ED) Using the Steripath® Blood Diversion Device
    Chawat Tongma, MD; Edward Ward, MD; Marites Gonzaga-Reardon, RN; Pamela Hagen, MT; Kamaljit Singh, MD
    Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
    Brandon Kulengowski, PharmD, MS; Matthew Brignola, BS; Chanah Gallagher, BA; W. Cliff Rutter, PharmD, MS; Julie A. Ribes, MD, PhD; David S. Burgess, PharmD, FCCP, FIDP
    Posters
  • PMB Etest vs. BMD Final.pdf (266.5 kB)
  • Retrospective Evaluation of Accelerate PhenoTM System (AXDX, Version 1.1) for Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) including Carbapenemase-Producing Organisms (CPO) from Seeded Blood Culture Bottles (SBCB) Tested using AXDX PhenoTestTM BC Kits
    Barbara M. Willey, ART; Bryan Gascon, BSc; Samantha Lee, BSc; Vita Koren, BSc; Salman Surangiwala, BSc; Aimee Paterson, MSc; Pauline Lo, MLT, ART; David A. Boyd, PhD; Michael Mulvey, PhD; Tony Mazzulli, MD FRCPC; Susan M. Poutanen, MD, MPH, FRCPC
    Analytical Performance Characteristics of the Accelerate PhenoTM System for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia
    Jason Burnham, MD; Meghan Wallace, BS; Brian Fuller, MD, MSCI; Carey-Ann D. Burnham, PhD; Marin Kollef, MD, FACP, FCCP
    Posters
  • AXDX.IDweek.2017.lab.final.pdf (446.0 kB)
  • Molecular Epidemiology of β-lactamase Production in Penicillin-susceptible Staphylococcus aureus under High-susceptibility Conditions
    Takashi Matono, MD; Maki Nagashima, MT; Kazuhisa Mezaki, MT; Ayano Motohashi, MT; Satoshi Kutsuna, MD, PhD; Kayoko Hayakawa, MD, PhD; Mitsuo Kaku, MD, PhD; Norio Ohmagari, MD, MSc, PhD
    Epidemiological and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae in a Tertiary Hospital in Korea: Possible Emergence of KPC-Producing Escherichia coli ST471 strain
    Jongyoun Yi, MD; Namhee Kim, MD; Mee Kyung Ko, BS; Hanwool Kim, MT; So Ra Kim, RN; Seung Hyun Hong, RN; Hyewon Kim, RN; Mi Jin Jang, RN; Sunhea Shin, RN; Mi Young Oh, RN; Nam Jeong Park, RN; Kye-Hyung Kim, MD
    Molecular serotype specific identification of Haemophilus influenzae using the loop-mediated isothermal amplification method.
    Mitsuko Seki, DDS, PhD; Chika Takano, MD; Paul Kilgore, MPH, MD; Koji Takahashi, MS; Dong Wook Kim, PhD; Satoshi Hayakawa, MD, PhD
    Descriptive Analysis of Cases with Suspected Infections that Used 16S ribosomal RNA PCR Testing
    Francisco Hernandez Munoz, MD; Armando Paez, MD; Paul Visintainer, PhD; Kristy Lindsey, MT (AMT); Franklin Moore, MD
    Posters
  • 2017.IDSA.paez.pdf (501.9 kB)
  • Comparative Phylogenomic Analysis of Escherichia coli ST131 Isolates and IncF-type Plasmids from North Carolina Community Hospitals and Other Regions of the United States
    Hajime Kanamori, MD, PhD, MPH; Timothy Johnson, PhD; Christian Parobek, PhD; Jonathan Juliano, MD, MSPH; James R. Johnson, MD; Brian D. Johnston, BA; David J. Weber, MD, MPH, FIDSA, FSHEA; William A. Rutala, PhD, MPH; Deverick Anderson, MD, MPH, FSHEA, FIDSA
    Posters
  • 20170922ST131_IDWeek2017.pdf (1.4 MB)
  • Comparison of the Sepsis-2 and Sepsis-3 Definitions of Sepsis and Their Ability to Predict Mortality in a Prospective Intensive Care Unit Cohort
    Debra D. Poutsiaka, MD, PhD, FIDSA; Maura Porto, MD; Whitney Perry, MD; Jana Hudcova, MD; David Tybor, PhD, MPH; Susan Hadley, MD, FIDSA; Shira Doron, MD, MS, FIDSA; John Adam Reich, MD; David Snydman, MD, FIDSA; Stanley Nasraway, MD
    A Whole Genome Sequencing (WGS) Approach to Predict Daptomycin (DAP) Susceptibility of Enterococcus faecium 
    German Contreras, MD MSc; Lorena Diaz, PhD; Rafael Rios, MSc; Katherine C. Reyes, MD, MPH; Mini Kamboj, MD; Jessica Lewis, MD; Sandra Rincon, MSc; Jinnethe Reyes, PhD; Lina Paola Carvajal, BSc; Diana Panesso, PhD; Costi D. Sifri, MD, FIDSA; Marcus Zervos, MD; Eric Pamer, MD; Truc T. Tran, PharmD; Samuel Shelburne, MD, PhD; Jose Munita, MD; Cesar Arias, MD, PhD, FIDSA
    Plasmid Promiscuity Explains High Endemicity of KPC-2 Among Colombian Enterobacteriaceae
    Ana Mercedes Rada, MSc; Elsa De La Cadena, MSc; Nataly Orozco, MSc; Carlos Agudelo Restrepo, MD, MSc; Cesar Capataz, MD; Marcela N Perenguez, BSc; Cristhian Hernández-Gómez, MSc; Christian Pallares, MD, MSc; Paola Porras, BSc; Javier Ardila, MSc; Rafael Ríos, MSc; Jinnethe Reyes, PhD; Lorena Diaz, PhD; Adriana Correa, PhD; Maria Virginia Villegas, MD, MSc, FIDSA; Cesar Arias, MD, PhD, FIDSA; Eliana Restrepo, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.